[144] Cencora, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Cencora, Inc. (COR) records a proposed sale of 31,350 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $9,140,092.50 and an approximate sale date of 09/16/2025. The filing breaks the lot into 2,000 shares acquired on 09/30/2023 by restricted stock vesting (compensation) and 29,350 shares tied to options granted on 11/13/2019 with a payment date of 09/16/2025 identified as cash.

The form also lists three recent insider sales by Steven Collis: 14,579 shares on 06/24/2025 for $4,266,106.98, 14,578 shares on 07/22/2025 for $4,266,543.26, and 14,579 shares on 08/19/2025 for $4,227,618.42. The notice includes the mandatory representation that the seller is not aware of undisclosed material adverse information.

Positive

• Provenance disclosed: The filing clearly states acquisition dates and the nature of acquisition (restricted stock vesting and options), aiding transparency.
• Attestation included: Seller represents no undisclosed material adverse information, meeting Rule 144 disclosure requirements.

Negative

• Substantial insider selling: Proposed sale of 31,350 shares (~$9.14M) and three recent sales totaling 43,736 shares (~$12.76M) could be interpreted as significant insider liquidity.
• Issuer details incomplete: The filing's issuer identification fields are blank in the provided content, limiting context about the specific issuer contact information.

Insights

Financial Analyst

TL;DR: Insider sales are substantial in absolute terms but appear structured; proposed sale of 31,350 shares totals about $9.14M at market.

The filing documents a scheduled sale under Rule 144 for 31,350 common shares via Fidelity with an aggregate value of $9,140,092.50 and a target sale date of 09/16/2025. The lot comprises 2,000 vested restricted shares (09/30/2023) and 29,350 shares tied to long-dated options granted 11/13/2019 with cash payment on 09/16/2025. Prior three-month transactions by Steven Collis show regular dispositions totaling 43,736 shares and gross proceeds of roughly $12.76M. For investors, the data reflect insider liquidity events; the filing itself provides no operational or financial performance details.

Corporate Governance Expert

TL;DR: Multiple scheduled and recent insider sales are disclosed; documentation includes the standard Rule 144 attestation.

The notice includes required provenance for the securities: restricted stock vesting and option-related transactions with explicit acquisition and payment dates. It also records three recent sales by an insider (Steven Collis) in the past three months, each disclosed with gross proceeds. The form contains the attestation that the seller lacks undisclosed material adverse information and shows no indication of reliance on a Rule 10b5-1 plan in the visible fields. Governance implications center on insider liquidity rather than corporate action; the filing contains no allegations, litigation, or unusual clauses.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	31350	9140092.50	193877881	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/30/2023	Restricted Stock Vesting	Issuer			2000	09/30/2023	Compensation
Common	09/16/2025	Options Granted - 11/13/2019	Issuer			29350	09/16/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Steven Collis 1 West First Avenue Conshohocken PA 19428-1800	Common	06/24/2025	14579	4266106.98
Steven Collis 1 West First Avenue Conshohocken PA 19428-1800	Common	07/22/2025	14578	4266543.26
Steven Collis 1 West First Avenue Conshohocken PA 19428-1800	Common	08/19/2025	14579	4227618.42

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares of Cencora (COR) are proposed for sale in this Form 144?

The notice proposes selling 31,350 common shares through Fidelity Brokerage Services with an aggregate market value of $9,140,092.50 and an approximate sale date of 09/16/2025.

How were the securities to be sold acquired?

The filing shows 2,000 shares from restricted stock vesting on 09/30/2023 (compensation) and 29,350 shares tied to options granted on 11/13/2019 with payment dated 09/16/2025 (cash).

Did the filer report recent insider sales?

Yes. Steven Collis reported sales of 14,579 shares on 06/24/2025 for $4,266,106.98, 14,578 shares on 07/22/2025 for $4,266,543.26, and 14,579 shares on 08/19/2025 for $4,227,618.42.

Where will the proposed shares be sold?

The securities are to be sold via Fidelity Brokerage Services LLC on the NYSE.

Does the Form 144 indicate reliance on a Rule 10b5-1 trading plan?

The visible fields do not show a date of plan adoption or explicit indication of reliance on a Rule 10b5-1 plan in the provided content.